Stephens & Co. Reiterates Equal-Weight on Treace Medical Concepts, Maintains $27 Price Target
Portfolio Pulse from richadhand@benzinga.com
Stephens & Co. analyst George Sellers reiterates an Equal-Weight rating on Treace Medical Concepts (NASDAQ:TMCI) and maintains a $27 price target.

June 02, 2023 | 12:21 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Stephens & Co. analyst George Sellers reiterates an Equal-Weight rating on Treace Medical Concepts (TMCI) and maintains a $27 price target.
The news is directly related to TMCI as the analyst reiterates an Equal-Weight rating and maintains a $27 price target. This indicates that the analyst's view on the stock has not changed, and the stock price is expected to remain stable in the short term. The importance is moderate as it is an analyst's opinion, and the confidence in the analysis is high as it is based on the analyst's expertise.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100